Johnson & Johnson has announced new data from an analysis modelling long-term progression free survival (PFS) in transplant ...

The approval follows October 2024's indication extension for daratumumab-VRd for newly diagnosed patients eligible for ASCT.

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved an indication extension of DARZALEX® (daratumumab) subcutaneous (SC) ...

Jensen-Munroe relapsed in 2023 and was told unfunded, $220,000-a-year drug daratumumab was her “best option”. Unable to afford that, last year she took the second option of a stem cell transplant.

The European Commission (EC) has approved an indication extension of Darzalex (daratumumab) subcutaneous (SC) formulation in ...

Halozyme (HALO) announced that Janssen-Cilag International, a Johnson & Johnson (JNJ) company, received European Commission approval for an ...

Daratumumab, hyaluronidase-fihj; 1800mg/30000units; per vial; soln for SC inj; preservative-free. Daratumumab binds to CD38 and inhibits the growth of CD38 expressing tumor cells by inducing ...

Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has received approval from the European Commission (EC) ...

The French river cruise prize package is sold for $29,000 to top bidder Dennis Walsh and Cathie Waites at Rotorua's Supper Club charity fundraiser. Vaishali McNeill, 15, died in a 2023 head-on ...